Form 4 · Filed Jul 10, 2026, 10:15 PM UTC
ANTX/AN2 Therapeutics, Inc.
Eizen Joshua M — See Remarks
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
1 row| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jul 8, 2026 | S | sell | 5,945 | $4 | $24,803 | 206,554 |
Source: SEC EDGAR raw filing ↗ · Accession 0001193125-26-301092